Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dapsone 7.5% Gel in Acne Vulgaris
NCT01974141Phase 3Completed
- Sponsor
- Almirall
- Start
- Nov 2013
- Primary completion
- Oct 2014
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 3 trial of dapsone in acne vulgaris, sponsored by Almirall. Started Nov 2013; status: completed.
02
Drugs
dapsone
03
Conditions
acne vulgaris
Beyond the preview
Go deeper on NCT01974141.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01974141.